Indegene Ltd (INDGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039241, "name": "Indegene", "stock_name": "Indegene", "full_name": "Indegene Ltd", "name_url": "stocks-analysis/indegene", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "554.10", "chg": 1.95, "chgp": "0.35%", "dir": 1, "prev_price": "552.15", "mcapval": "13,318.00 Cr", "mcap": "Small Cap", "scripcode": 544172, "symbol": "INDGN", "ind_name": "Healthcare Services", "ind_code": 57, "sector_id": 35, "indexname": "India SENSEX", "isin": "INE065X01017", "curr_date": "Aug 07, 03:30 PM", "curr_time": "01:56 AM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "10.18 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indegene-10039241-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Indegene Ltd Gains 7.61%: 3 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-gains-761-3-key-factors-driving-the-weeks-momentum-4142708", "imagepath": "", "date": "2026-08-08 10:05:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Valuation shifts signal changing market perception</p>\n <p><strong>5 Aug:</strong> Upgraded to Buy on strong financial and technical momentum</p>\n <p><strong>5 Aug:</strong> Technical momentum shifts to bullish amid sector recovery</p>\n <p><strong>7 Aug:</strong> Week closes at Rs.554.10 (+7.61%) outperforming Sensex</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.514.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..." }, { "title": "Indegene Ltd Upgraded to Buy on Strong Financial and Technical Momentum", "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-upgraded-to-buy-on-strong-financial-and-technical-momentum-4137414", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndegeneLtd_mojoScore_4137414.png", "date": "2026-08-05 08:45:18", "description": "Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across financial performance, technical indicators, and valuation metrics. The upgrade, effective from 4 August 2026, is underpinned by robust quarterly results, positive financial trends, and bullish technical signals, despite a shift to a more expensive valuation grade." }, { "title": "Indegene Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Healthcare Sector Recovery", "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-healthcare-sector-recovery-4137183", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndegeneLtd_technicaldot_4137183.png", "date": "2026-08-05 08:07:41", "description": "Indegene Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by a series of positive signals across key technical indicators, reflecting improving investor sentiment and robust price action in the healthcare services sector." }, { "title": "Indegene Ltd Valuation Shifts Signal Changing Market Perception", "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-valuation-shifts-signal-changing-market-perception-4132873", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndegeneLtd_valuationdot_4132873.png", "date": "2026-08-03 08:01:24", "description": "Indegene Ltd, a notable player in the healthcare services sector, has experienced a significant shift in its valuation parameters, prompting a downgrade in its mojo grade from Buy to Hold. With its price-to-earnings (P/E) ratio rising to 29.78 and price-to-book value (P/BV) climbing to 3.95, the stock now trades at a premium compared to its historical averages and many peers, signalling a more cautious stance for investors." }, { "title": "Are Indegene Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-indegene-ltd-latest-results-good-or-bad-4130692", "imagepath": "", "date": "2026-07-31 19:22:33", "description": "Indegene Ltd's latest financial results for Q1 FY27 present a complex picture characterized by strong revenue growth but challenges in profitability. The company reported net sales of ₹1,063.10 crores, reflecting a year-on-year growth of 39.73% and a sequential increase of 5.95% from the previous quarter. This marks the highest quarterly revenue in the company's history, indicating successful market penetration and demand for its services.\n\nHowever, the net profit for the quarter stood at ₹116.20 crores, which represents a marginal decline of 0.17% year-on-year, despite a significant sequential improvement of 45.80% from ₹79.70 crores in Q4 FY26. This juxtaposition highlights a critical concern: while revenue is expanding, the company's ability to convert this growth into profit is under pressure, as evidenced by the operating margin, which contracted to 16.39% from 20.41% in the same quarter last year. The..." }, { "title": "Indegene Q1 FY27: Strong Revenue Growth Masks Margin Erosion Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/indegene-q1-fy27-strong-revenue-growth-masks-margin-erosion-concerns-4130372", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Indegene_quaterlyResult_4130372.png", "date": "2026-07-31 09:54:45", "description": "Indegene Limited, a healthcare services provider with a market capitalisation of ₹12,806.89 crores, reported a flat net profit of ₹116.20 crores for Q1 FY27, virtually unchanged from ₹116.40 crores in the same quarter last year, representing a marginal decline of 0.17%. Despite robust revenue growth of 39.73% year-on-year, the company's profitability failed to keep pace, raising questions about operational efficiency and cost management. The stock traded at ₹531.60 on July 31, 2026, up 3.32% on the day, though it remains down 10.88% from its 52-week high of ₹596.50." }, { "title": "Indegene Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-hold-4124029", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndegeneLtd_mojoScore_4124029.png", "date": "2026-07-28 10:11:53", "description": "Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Indegene Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-hold-by-marketsmojo-4106176", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndegeneLtd_mojoScore_4106176.png", "date": "2026-07-17 10:11:00", "description": "Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Indegene Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-hold-by-marketsmojo-4090535", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/IndegeneLtd_mojoScore_4090535.png", "date": "2026-07-06 10:11:01", "description": "Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 257, "sid": "10039241", "stock_news_url": "https://www.marketsmojo.com/news/indegene-10039241" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "06-Aug-2026", "details": "Transcript of earnings conference call on financial results for the quarter ended June 30 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "01-Aug-2026", "details": "Intimation of Newspaper Publication", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "31-Jul-2026", "details": "Audio Recording of the Q1 FY27 Earnings Call", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Indegene Ltd has declared <strong>112%</strong> dividend, ex-date: 31 Jul 26", "dt": "2026-07-31", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Valuation shifts signal changing market perception

5 Aug: Upgraded to Buy on strong financial and technical momentum

5 Aug: Technical momentum shifts to bullish amid sector recovery

7 Aug: Week closes at Rs.554.10 (+7.61%) outperforming Sensex

Week Open

Rs.514.90

Week Close

Read full news article

Indegene Ltd Upgraded to Buy on Strong Financial and Technical Momentum

2026-08-05 08:45:18

Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across financial performance, technical indicators, and valuation metrics. The upgrade, effective from 4 August 2026, is underpinned by robust quarterly results, positive financial trends, and bullish technical signals, despite a shift to a more expensive valuation grade.

Read full news article

Indegene Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Healthcare Sector Recovery

2026-08-05 08:07:41

Indegene Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by a series of positive signals across key technical indicators, reflecting improving investor sentiment and robust price action in the healthcare services sector.

Read full news article

Indegene Ltd Valuation Shifts Signal Changing Market Perception

2026-08-03 08:01:24

Indegene Ltd, a notable player in the healthcare services sector, has experienced a significant shift in its valuation parameters, prompting a downgrade in its mojo grade from Buy to Hold. With its price-to-earnings (P/E) ratio rising to 29.78 and price-to-book value (P/BV) climbing to 3.95, the stock now trades at a premium compared to its historical averages and many peers, signalling a more cautious stance for investors.

Read full news article

Are Indegene Ltd latest results good or bad?

2026-07-31 19:22:33

Indegene Ltd's latest financial results for Q1 FY27 present a complex picture characterized by strong revenue growth but challenges in profitability. The company reported net sales of ₹1,063.10 crores, reflecting a year-on-year growth of 39.73% and a sequential increase of 5.95% from the previous quarter. This marks the highest quarterly revenue in the company's history, indicating successful market penetration and demand for its services. However, the net profit for the quarter stood at ₹116.20 crores, which represents a marginal decline of 0.17% year-on-year, despite a significant sequential improvement of 45.80% from ₹79.70 crores in Q4 FY26. This juxtaposition highlights a critical concern: while revenue is expanding, the company's ability to convert this growth into profit is under pressure, as evidenced by the operating margin, which contracted to 16.39% from 20.41% in the same quarter last year. The...

Read full news article

Indegene Q1 FY27: Strong Revenue Growth Masks Margin Erosion Concerns

2026-07-31 09:54:45

Indegene Limited, a healthcare services provider with a market capitalisation of ₹12,806.89 crores, reported a flat net profit of ₹116.20 crores for Q1 FY27, virtually unchanged from ₹116.40 crores in the same quarter last year, representing a marginal decline of 0.17%. Despite robust revenue growth of 39.73% year-on-year, the company's profitability failed to keep pace, raising questions about operational efficiency and cost management. The stock traded at ₹531.60 on July 31, 2026, up 3.32% on the day, though it remains down 10.88% from its 52-week high of ₹596.50.

Read full news article

Indegene Ltd is Rated Hold

2026-07-28 10:11:53

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Indegene Ltd is Rated Hold by MarketsMOJO

2026-07-17 10:11:00

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Indegene Ltd is Rated Hold by MarketsMOJO

2026-07-06 10:11:01

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article